Today: 10 June 2026
Browse Category

NASDAQ:LRCX 15 January 2026 - 26 January 2026

Lam Research stock drops again — what to watch before LRCX earnings next week

Lam Research stock drops again — what to watch before LRCX earnings next week

Lam Research shares fell 1.3% to $217.94 Friday, extending a three-day slide as chip equipment stocks reacted to Intel’s weak outlook. Trading volume was below average, with Lam closing about 7.7% under its 52-week high. Investors are focused on Lam’s January 28 earnings for signals on chipmaking tool demand. Wall Street expects quarterly earnings of $1.17 per share on $5.23 billion revenue.
Applied Materials (AMAT) stock slides after hours as Feb. 12 earnings date nears

Applied Materials (AMAT) stock slides after hours as Feb. 12 earnings date nears

Applied Materials shares fell about 2% to $318.79 in after-hours trading Thursday after a volatile session, despite the S&P 500 and Dow both rising. The company set its fiscal first-quarter earnings release and call for Feb. 12. Options activity spiked near the $330 strike ahead of Friday’s expiration. Lam Research and KLA also declined, pressuring chip equipment stocks.
Lam Research stock slips 3% after fresh high as Citi, Deutsche Bank lift targets into earnings

Lam Research stock slips 3% after fresh high as Citi, Deutsche Bank lift targets into earnings

Lam Research shares fell 3.4% to $220.70 Thursday, slipping from a 52-week high reached the previous day. The decline came despite Citi and Deutsche Bank raising their price targets ahead of Lam’s Jan. 28 earnings. Investors are watching for 2026 chip-equipment spending forecasts, not just quarterly results. Lam’s trading volume was near average as the S&P 500 rose 0.6%.
Applied Materials stock rebounds after tariff scare fades; what to watch next for AMAT

Applied Materials stock rebounds after tariff scare fades; what to watch next for AMAT

Applied Materials rose 2.2% to $325.24 Wednesday, rebounding after Trump said he would delay tariffs tied to Greenland talks. Trading volume topped the 50-day average. Needham raised its price target to $390. The company warned of weaker China equipment spending in 2026 due to tighter U.S. export controls.
Lam Research stock climbs as Deutsche Bank lifts target ahead of Jan. 28 earnings

Lam Research stock climbs as Deutsche Bank lifts target ahead of Jan. 28 earnings

Lam Research shares rose 2.6% to $228.39 in after-hours trading Wednesday after multiple analysts raised price targets ahead of next week’s earnings. Analysts cited strong demand and accelerated chip equipment orders, with Deutsche Bank, UBS, and Needham all boosting targets and maintaining Buy ratings. Applied Materials, KLA, and ASML shares also gained. Lam reports results Jan. 28.
Lam Research stock swings on tariff jitters as UBS lifts target ahead of earnings

Lam Research stock swings on tariff jitters as UBS lifts target ahead of earnings

Lam Research shares closed down 0.25% Tuesday, holding near $222 in muted after-hours trading as tariff threats from President Trump pressured tech stocks. UBS raised its price target on Lam to $255, citing strong Q2 prospects. Lam’s earnings report is set for Jan. 28. Applied Materials and KLA fell more sharply, dropping 2.7% and 5.2% respectively.
Lam Research (LRCX) stock holds up after Taiwan tool order, Needham target hike as markets slide

Lam Research (LRCX) stock holds up after Taiwan tool order, Needham target hike as markets slide

Lam Research shares were little changed Tuesday after Winbond Electronics announced a T$6.81 billion ($215.66 million) equipment order from a Lam subsidiary. Needham raised its price target for Lam to $250 from $160. The stock traded at $223.01 by late morning. Investors are watching Lam’s Jan. 28 earnings for signals on chip-factory spending.
Applied Materials (AMAT) stock price ends higher as KeyBanc lifts target; traders size up week ahead

Applied Materials (AMAT) stock price ends higher as KeyBanc lifts target; traders size up week ahead

Applied Materials shares rose 2.5% to $327.01 Friday, outpacing the broader market after KeyBanc raised its price target to $380. The move followed TSMC’s higher 2026 capex forecast, which boosted chip-equipment stocks. U.S. markets are closed Monday for Martin Luther King Jr. Day. Applied reports earnings Feb. 12.
Applied Materials stock price holds near $327 after TSMC capex jolt — what to watch next

Applied Materials stock price holds near $327 after TSMC capex jolt — what to watch next

Applied Materials closed up 2.5% at $327.01 Friday, lifted by TSMC’s announcement of a $52–$56 billion 2026 spending plan. U.S. markets will be shut Monday for Martin Luther King Jr. Day. Applied’s earnings call is set for Feb. 12, with analysts expecting a 7.1% year-over-year profit drop. The company has warned U.S. export controls could cut 2026 revenue by $600 million.
KLA stock price holds near highs after Wells Fargo upgrade as TSMC capex lifts chip tools

KLA stock price holds near highs after Wells Fargo upgrade as TSMC capex lifts chip tools

KLA Corp shares rose 1.4% to $1,567.82 Friday, buoyed by a Wells Fargo upgrade and strong chip equipment sector gains. The move followed TSMC’s $52–56 billion 2026 capex forecast and a $250 billion U.S.-Taiwan chip trade deal. Investors are watching for signs of increased spending on advanced chips. KLA reports fiscal Q2 results after markets close Jan. 29.
Lam Research stock rises after hours as TSMC capex signal and analyst upgrades lift chip tools

Lam Research stock rises after hours as TSMC capex signal and analyst upgrades lift chip tools

Lam Research shares jumped 4.2% to $217.47 in after-hours trading Thursday, following broker upgrades and TSMC’s announcement of higher 2026 spending plans. Applied Materials, KLA, and U.S.-listed TSMC shares also posted strong gains. Wells Fargo, RBC Capital, Stifel, Morgan Stanley, and Barclays all raised price targets for Lam, citing robust demand in wafer-fab equipment and AI-related growth.
1 2 3 4 5 6 10

Stock Market Today

  • BIO-key Receives Nasdaq Notice for Delayed 10-Q Filing
    June 10, 2026, 5:45 PM EDT. BIO-key International, Inc. (OTC: BKYI) received a non-compliance notice from Nasdaq for failing to file its Quarterly Report on Form 10-Q for Q1 2026 on time as required by Nasdaq Listing Rule 5250(c)(1). Nasdaq's notification states the company's delay could affect its continued listing on the Nasdaq Capital Market pending a Hearing Panel determination. BIO-key specializes in biometric authentication and identity access management (IAM) technologies. The company serves over 40 million users with its cloud-hosted and on-premise PortalGuard IAM solution, supporting secure, multi-factor authentication options including passwordless methods. This regulatory development adds pressure on BIO-key to meet reporting requirements amid its efforts to secure market confidence.

Latest articles

Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Snap Inc. Targets Health Ad Dollars With New Snapchat Study as Pressure Builds

Snap Shares Drop Again With Tech Names Under Pressure

10 June 2026
Snap Inc. shares slid 4% to $5.38, extending a three-day losing streak and deepening doubts about its turnaround despite improved cash flow and cost cuts, as investors await CEO Evan Spiegel’s June 16 AWE keynote and weigh weak ad growth, falling eCPMs, and ongoing macro and regulatory risks.
Go toTop